|
|||
|
| ||
by Emmanuel A. Bouzas
|
|
Antibiotics with high potency against pathogenic antibiotic resistant bacterial strains are expected to be of great value in the clinic. Abyssomicin C is a serious candidate since it possess an unprecedent complicated structure and an impressive biological profile. Abyssomicin C, inhibits the biosynthesis of p-amino-benzoic acid (a pathway existing in bacteria but not in humans) and it is highly potent against resistant Staphylococcus aureus strains (MRSA and VRSA). Efficient chemical routes for the preparation of Abyssomicin C, as well as of related analogues, will have to be invented in order to facilitate possible pharmaceutical application of the new architecture. Not surprisingly many synthetic chemistry groups were alerted and two years after its discovery two elegant total and two formal syntheses have been released. However, the applicability of all the up-to-date synthetic routes for scaling up and further derivatization of Abyssomicin C is questionable, especially due to low to moderate yields of certain steps. Thus, our major scope at the present is to develop novel approaches for an improved synthesis of Abyssomycin C in multi-gram scale that will lead to the preparation of designed derivatives. |
| ||||
|
|
|
Edited by Emmanuel A. Bouzas
Prof. Elias A. Couladouros
E-Mail: ecoula@aua.gr
Last Updated: [17-9-2009]